C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof

Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673)
01/2003
01/02/2003	US20030003475 Arrays for detecting nucleic acids
01/02/2003	EP1270596A1 Antibody/carrier complex, process for producing the same, method of controlling antigen-antibody reaction by using the same and immunoassay method
01/02/2003	EP1270030A1 Adsorbents for dilated cardiomyopathy
01/02/2003	EP1268626A1 A porous, molecularly imprinted polymer and a process for the preparation thereof
01/02/2003	EP0885244B1 Peptide immunogens for vaccination against and treatment of allergy
12/2002
12/31/2002	US6500647 Recombinant expression vector which is prepared by inserting a human parathyroid hormone gene containing a urokinase-specific cleavage site into an l-arabinose inducible vector containing a phosphoribulokinase gene fragment of
12/31/2002	CA1341414C Expression vectors of hirudine, transformed cells and process for the preparation of hirudine
12/30/2002	CA2841397A1 Novel compositions and processes for improved analyte detection using hybridization assays
12/30/2002	CA2841389A1 Novel compositions and processes for improved analyte detection using hybridization assays
12/30/2002	CA2714119A1 Novel compositions and processes for improved analyte detection using hybridization assays
12/27/2002	WO2001079300A9 Surface-bound antigen binding portions of antibodies that bind to ctla-4 and cd28 and uses therefor
12/26/2002	US20020198360 Structural models for cytoplasmic domains of transmembrane receptors
12/26/2002	US20020197389 Functionalized silicon surfaces
12/24/2002	US6497879 Composition which comprises isolated mage-10 tumor rejection antigen precursor which is encoded by nucleic acid having specified nucleotide sequence
12/19/2002	WO2002092615A3 Compositions and methods for array-based genomic nucleic acid analysis of biological molecules
12/19/2002	US20020192693 Apparatus for polymer synthesis
12/19/2002	US20020192684 Arrays for detecting nucleic acids
12/18/2002	EP1265910A2 Nucleic acids, proteins, and antibodies
12/17/2002	US6495136 Proteases having modified amino acid sequences conjugated to addition moieties
12/12/2002	WO2002099099A2 Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications
12/12/2002	WO2002079232A3 Reducing the immunogenicity of fusion proteins
12/12/2002	US20020188102 Peptide for use as microbiocides
12/11/2002	EP1263944A2 Nucleic acids, proteins, and antibodies
12/11/2002	EP1263784A1 Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes
12/11/2002	EP1263327A1 Biocompatible material composition adaptable to diverse therapeutic indications
12/10/2002	US6491871 System for determining receptor-ligand binding affinity
12/10/2002	CA2311684C Chemically-modified g-csf
12/05/2002	WO2002097118A1 Method for producing a layer of functional molecules
12/05/2002	WO2002097051A2 Protein arrays and methods and systems for producing the same
12/05/2002	WO2002062957A9 Ter sites and ter binding proteins
12/05/2002	WO2002042321A3 Mixed fibrils
12/05/2002	WO2001098362A3 Chemically-modified antimicrobial peptides, compositions and methods of production and use
12/05/2002	US20020183505 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/05/2002	US20020183494 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/05/2002	US20020183493 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/05/2002	US20020182687 Generation of adaptor nucleotide sequence particles; obtain nucleotide sequences, incubate with adaptor, join, recover adaptor nucleotide sequences
12/05/2002	US20020182638 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/05/2002	US20020182597 Used for screening for protein-compound interactions such as protein- therapeutic compound interactions
12/05/2002	US20020182209 Leukemic cell-adsorbing column and adsorbent material therefor
12/05/2002	DE10124872A1 Fabrication of microdevices for separation of biomolecules in an electric field involves a vapor deposition coating process with the coating including functional groups having an intrinsic reactivity to react with target molecules
12/05/2002	CA2447226A1 Method for producing a layer of functional molecules
12/04/2002	EP1261745A2 Nucleic acids, proteins, and antibodies
12/04/2002	EP1261703A1 Nucleic acids, proteins, and antibodies
12/04/2002	EP1261637A1 Nucleic acids, proteins, and antibodies
12/04/2002	EP1261634A1 Nucleic acids, proteins, and antibodies
12/04/2002	EP1261633A2 Nucleic acids, proteins, and antibodies
12/04/2002	EP1261631A1 A 52 kDa PROTEIN FROM COAGULASE NEGATIVE STAPHYLOCOCCI AND FRAGMENTS THEREOF
12/04/2002	EP1261618A2 Nucleic acids, proteins, and antibodies
12/04/2002	EP1261380A1 Nucleic acids, proteins and antibodies
12/04/2002	EP0690915B1 Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof
12/03/2002	US6489159 Polymeric target constituents selected from the group consisting of nucleic acids and peptides immobilized on a surface of a solid support
12/03/2002	US6489102 Made using a reversible protecting group to reversibly modify omega-functionalized alkanethiols self-assembled on metal substrates, and immobilizing cells or biomolecules; use in surface plasmon resonance (spr) imaging
11/2002
11/28/2002	WO2002095075A1 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
11/28/2002	WO2002094029A1 Method of inhibiting fungal growth
11/28/2002	WO2002072631A8 Mhc molecule constructs and their usesfor diagnosis and therapy
11/28/2002	US20020177688 Genetically engineered polypeptide for use in the treatment of infections, inflammation, hematopietic, bone and wound disorders
11/28/2002	US20020177158 Detection of preferential protein in sample; obtain pool of proteins, incubate with probe, detect signal from probe, recover proteins
11/28/2002	US20020177128 Variant of LAV viruses
11/28/2002	CA2755964A1 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
11/27/2002	EP1260582A1 Conjugates of factor IX and a biocompatible polymer
11/27/2002	EP1259642A1 Nucleic acids, proteins, and antibodies
11/27/2002	EP1259541A2 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
11/27/2002	EP1259540A1 Nucleic acids, proteins, and antibodies
11/27/2002	EP1259531A2 Nucleic acids, proteins, and antibodies
11/27/2002	EP1259526A2 Nucleic acids, proteins, and antibodies
11/27/2002	EP0871649B1 Conjugates of a polypeptide and a biocompatible polymer
11/26/2002	US6485986 Functionalized silicon surfaces
11/26/2002	US6485984 Calixcrown derivatives, a process for the preparation thereof, a self-assembled mono-layer of the calixcrown derivatives prepared by using the same and a process for immobilizing a protein mono-layer by using the self-assembled mono-layer of the calixcrown derivatives
11/26/2002	CA2256766C Materials and methods for the immobilization of bioactive species onto polymeric substrates
11/21/2002	WO2002092788A2 Cytotoxic peptides and peptidomimetics based thereon, and methods for use thereof
11/21/2002	WO2002092615A2 Compositions and methods for array-based genomic nucleic acid analysis of biological molecules
11/21/2002	US20020173007 Human chemokine polypeptides
11/21/2002	CA2446050A1 Compositions and methods for array-based genomic nucleic acid analysis of biological molecules
11/21/2002	CA2443160A1 Cytotoxic peptides and peptidomimetics based thereon, and methods for use thereof
11/20/2002	EP1258497A2 Conjugates of factor VIII and a biocompatible polymer
11/20/2002	EP0954326A4 A process for viral inactivation of lyophilized blood proteins
11/20/2002	EP0865323B1 Method of oriented depositing chemically defined bodies
11/14/2002	US20020169281 Peptoids incorporating chemoselective functionalities
11/14/2002	US20020169264 Acylation with an acryloyl group of an amino group at some point in the peptide sequence, while still attached to the solid phase support with side chain groups intact, followed by deprotecting and free radical polymerization; vaccines
11/14/2002	US20020168628 Variant of LAV viruses
11/13/2002	EP1255864A1 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255817A1 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255778A2 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255777A1 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255776A1 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255768A2 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255767A2 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255766A2 Nucleic acids, proteins, and antibodies
11/13/2002	CN1379687A Magnetic nanoparticles having biochemial activity, method for production thereof and their use
11/12/2002	US6479457 Polypeptide comprising at least one effective ionogenic amine ionically bound to polymer; drug delivery systems for the controlled release of pharmaceutical polypeptides
11/12/2002	US6479261 Methods of using interleukin-3 (IL-3) mutant polypeptides for ex-vivo expansion of hematopoietic stem cells
11/07/2002	US20020164590 Solid support for use in the determination, classification and mapping of biopolymer sequences
11/06/2002	EP1254248A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254219A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254218A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254173A1 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254172A1 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254153A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254152A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254151A1 Nucleic acids, proteins, and antibodies

1 ... 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 ... 107